Search Results - "Cramer, M. J."

High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes by Boonman-de Winter, L. J. M., Rutten, F. H., Cramer, M. J. M., Landman, M. J., Liem, A. H., Rutten, G. E. H. M., Hoes, A. W.

“…Aims/hypothesis The aim of this study was to assess the prevalence of (unknown) heart failure and left ventricular dysfunction in older patients with type 2…”
Get full text

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes by Sharif, Shahnam, Van der Graaf, Y, Cramer, M J, Kapelle, L J, de Borst, G J, Visseren, Frank L J, Westerink, Jan

“…Type 2 diabetes is a condition associated with a state of low-grade inflammation caused by adipose tissue dysfunction and insulin resistance. High…”
Get full text

A prospective validation of the HEART score for chest pain patients at the emergency department by Backus, B.E, Six, A.J, Kelder, J.C, Bosschaert, M.A.R, Mast, E.G, Mosterd, A, Veldkamp, R.F, Wardeh, A.J, Tio, R, Braam, R, Monnink, S.H.J, van Tooren, R, Mast, T.P, van den Akker, F, Cramer, M.J.M, Poldervaart, J.M, Hoes, A.W, Doevendans, P.A

“…Abstract Background The focus of the diagnostic process in chest pain patients at the emergency department is to identify both low and high risk patients for…”
Get full text

Recommendations on how to provide cardiac rehabilitation services during the COVID-19 pandemic by Kemps, H. M. C., Brouwers, R. W. M., Cramer, M. J., Jorstad, H. T., de Kluiver, E. P., Kraaijenhagen, R. A., Kuijpers, P. M. J. C., van der Linde, M. R., de Melker, E., Rodrigo, S. F., Spee, R. F., Sunamura, M., Vromen, T., Wittekoek, M. E.

“…The ongoing coronavirus disease 2019 (COVID-19) crisis is having a large impact on acute and chronic cardiac care. Due to public health measures and the…”
Get full text

Unrecognized heart failure and chronic obstructive pulmonary disease (COPD) in frail elderly detected through a near-home targeted screening strategy by van Mourik, Yvonne, Bertens, Loes C M, Cramer, Maarten J M, Lammers, Jan-Willem J, Reitsma, Johannes B, Moons, Karel G M, Hoes, Arno W, Rutten, Frans H

“…Reduced exercise tolerance and dyspnea are common in older people, and heart failure (HF) and chronic obstructive pulmonary disease (COPD) are the main causes…”
Get full text

Cardio-oncology: an overview on outpatient management and future developments by Teske, A. J., Linschoten, M., Kamphuis, J. A. M., Naaktgeboren, W. R., Leiner, T., van der Wall, E., Kuball, J., van Rhenen, A., Doevendans, P. A., Cramer, M. J., Asselbergs, F. W.

“…Recent advances in the early detection and treatment of cancer have led to increasing numbers of cancer survivors worldwide. Nonetheless, despite major…”
Get full text

Echocardiographic quantification of myocardial function using tissue deformation imaging, a guide to image acquisition and analysis using tissue Doppler and speckle tracking by Teske, Arco J, De Boeck, Bart W L, Melman, Paul G, Sieswerda, Gertjan T, Doevendans, Pieter A, Cramer, Maarten J M

“…Recent developments in the field of echocardiography have allowed the cardiologist to objectively quantify regional and global myocardial function. Regional…”
Get full text

Low High-Density Lipoprotein Cholesterol Is Not a Risk Factor for Recurrent Vascular Events in Patients With Vascular Disease on Intensive Lipid-Lowering Medication by van de Woestijne, Anton P., MD, van der Graaf, Yolanda, MD, PhD, Liem, An-Ho, MD, PhD, Cramer, Maarten J.M., MD, PhD, Westerink, Jan, MD, PhD, Visseren, Frank L.J., MD, PhD

“…Objectives This study sought to evaluate the vascular risk of low high-density lipoprotein-cholesterol (HDL-C) in relation to the use and intensity of…”
Get full text

ONCOR: design of the Dutch cardio-oncology registry by Kamphuis, J. A. M., Linschoten, M., Cramer, M. J., Alsemgeest, F., van Kessel, D. J. W., Urgel, K., Post, M. C., Manintveld, O. C., Hassing, H. C., Liesting, C., Wardeh, A. J., Olde Bijvank, E. G. M., Schaap, J., Stevense-den Boer, A. M., Doevendans, P. A., Asselbergs, F. W., Teske, A. J.

“…Background The relative new subspecialty ‘cardio-oncology’ was established to meet the growing demand for an interdisciplinary approach to the management of…”
Get full text

How I do it: feasibility of a new ultrasound probe fixator to facilitate high quality stress echocardiography by Salden, O A E, van Everdingen, W M, Spee, R, Doevendans, P A, Cramer, M J

“…Stress echocardiography (SE) has recently regained momentum as an important diagnostic tool for the assessment of both ischemic and non-ischemic heart disease…”
Get full text

Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline by Lafeber, M, Stades, A M E, Valk, G D, Cramer, M J, Teding van Berkhout, F, Zelissen, P M J

“…BackgroundCabergoline, a dopamine agonist used to treat hyperprolactinemia, is associated with an increased risk of fibrotic adverse reactions, e.g. cardiac…”
Get full text

Survival analysis of patients with rheumatic MS after PBMV compared with MVS in a low-to-middle-income country by Ambari, A. M., Setianto, B., Santoso, A., Dwiputra, B., Radi, B., Alkatiri, A. A., Adji, A. B., Susilowati, E., Tulrahmi, F., Cramer, M. J. M., Doevendans, P. A.

“…Introduction Rheumatic mitral stenosis continues to be prevalent in developing countries, notably in endemic areas. Over the last few decades, percutaneous…”
Get full text

Retrospective analysis of endocarditis patients to investigate the eligibility for oral antibiotic treatment in routine daily practice by Vroon, J. C., Liesdek, O. C. D., Boel, C. H. E., Arends, J. E., Niessen, F. A., van Heusden, H. C., Cramer, M. J., van der Spoel, T. I. G., Chamuleau, S. A. J.

“…Background According to the current guidelines of the European Society of Cardiology, patients with left-sided infective endocarditis are treated with…”
Get full text

Left ventricular hypertrophy: a shift in paradigm by Meijs, M F L, de Windt, L J, de Jonge, N, Cramer, M-J M, Bots, M L, Mali, W P Th M, Doevendans, P A

“…Observational studies have identified left ventricular hypertrophy (LVH) as a strong, independent risk factor for the development of heart failure (HF),…”
Get more information

Feasibility and potential benefit of pre-procedural CMR imaging in patients with ischaemic cardiomyopathy undergoing cardiac resynchronisation therapy by Gathier, W. A., Salden, O. A. E., van Ginkel, D. J., van Everdingen, W. M., Mohamed Hoesein, F. A. A., Cramer, M. J. M., Doevendans, P. A., Meine, M., Chamuleau, S. A. J., van Slochteren, F. J.

“…Aim To determine the feasibility and potential benefit of a full cardiac magnetic resonance (CMR) work-up for assessing the location of scarred myocardium and…”
Get full text

Differentiation of white-footed mice (Peromyscus leucopus) and deer mice (Peromyscus maniculatus) of the Upper Midwest using PCR melt curve analysis by Ridenhour, B. J, Cramer, M. J

“…Cryptic species pairs including white-footed mice, Peromyscus leucopus, and deer mice, Peromyscus maniculatus, are difficult to identify using morphological…”
Get full text

Longitudinal echocardiographic and clinical follow-up of patients undergoing mitral valve surgery without concomitant tricuspid valve repair by Jansen, R., van Klarenbosch, B. R., Cramer, M. J., Meijer, R. C. A., Westendorp, P. H. M., Meijburg, H. W. J., Bucx, J. J. J., Chamuleau, S. A. J., Kluin, J.

“…Background In patients with mild to moderate functional tricuspid regurgitation (TR) and absence of right ventricular dysfunction or tricuspid annulus (TA)…”
Get full text

Autologous Mesenchymal Stem Cells Show More Benefit on Systolic Function Compared to Bone Marrow Mononuclear Cells in a Porcine Model of Chronic Myocardial Infarction by van der Spoel, T. I. G., Gathier, W. A., Koudstaal, S., van Slochteren, F., of Lorkeers, S. Jansen, Sluijter, J. P. G., Hoefer, I. E., Steendijk, P., Cramer, M. J. M., Doevendans, P. A., van Belle, E., Chamuleau, S. A. J.

“…Cardiac cell therapy is a strategy to treat patients with chronic myocardial infarction (MI). No consensus exists regarding the optimal cell type. First, a…”
Get full text

Clinical characterisation and risk stratification of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy ≥50 years of age by van der Pols, M. J., Mast, T. P., Loh, P., van der Heijden, J. F., Cramer, M. J., Hauer, R. N., te Riele, A. S. J. M.

“…Purpose With the increased use of genetic testing for arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C), this disease is being increasingly…”
Get full text

Uncovering heart failure with preserved ejection fraction in patients with type 2 diabetes in primary care: time for a change by Boonman-de Winter, L. J. M., Cramer, M. J., Hoes, A. W., Rutten, F. H.

“…Undetected heart failure appears to be an important health problem in patients with type 2 diabetes and aged ≥ 60 years. The prevalence of previously unknown…”
Get full text